Barclays raised the firm’s price target on Veeva (VEEV) to $325 from $300 and keeps an Overweight rating on the shares. The company reported better Q2 billings and revenue as Crossix continues to take share, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VEEV: